The Company and Summary of Significant Accounting Policies (Details)	12 Months Ended				284 Months Ended	12 Months Ended			6 Months Ended	12 Months Ended
	Dec. 31, 2013 USD ($)	Dec. 31, 2013 EUR (€)	Dec. 31, 2012 USD ($)	Dec. 31, 2012 EUR (€)	Dec. 31, 2013 EUR (€)	Dec. 31, 2013 Accounts Receivable [Member]	Dec. 31, 2013 Convertible Loans [Member]	Dec. 31, 2012 Convertible Loans [Member]	Jun. 30, 2013 Warrants [Member]	Dec. 31, 2012 Warrants [Member]	Dec. 31, 2013 Stock Options [Member]	Dec. 31, 2012 Stock Options [Member]
Basis of Presentation [Abstract]
Deficit accumulated during the development stage		€ 64,165,000		€ 70,168,000	€ 64,165,000
Amount of current liabilities exceed its current assets		35,915,000			35,915,000
License fee received	5,000,000	4,381,000		0	4,381,000
Revenue Recognition [Abstract]
Period to earn royalty payments after first commercial sale	10 years	10 years
Milestone payments received	62,000,000
Property and Equipment[Abstract]
Estimated useful lives	3 years	3 years
Taxes on Income [Abstract]
Income tax contingency open tax years	December 31, 2009 to 2013	December 31, 2009 to 2013
Earnings per Share [Abstract]
Weighted average number of shares (in shares)	295,384,566	295,384,566	293,959,795	293,959,795
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	487,547,813	487,547,813	121,884,529	121,884,529			466,697,813	86,202,029		32,000,000	20,850,000	3,692,500
Expired (in shares)	332,500	332,500	1,060,000	1,060,000					32,000,000
Fair value of the contingent consideration	$ 325,000
Preferred Stock [Abstract]
Preferred stock, shares authorized (in shares)	5,000,000	5,000,000	5,000,000	5,000,000
Preferred stock, shares issued (in shares)	0	0	0	0
Preferred stock, shares outstanding (in shares)	0	0	0	0
Stock Options [Abstract]
Incentive stock options awarded (in shares)	20,600,000	20,600,000	0	0
Exercise price of shares granted (in dollars per share)	$ 0.02		$ 0
Shares vested (in shares)	3,300,000	3,300,000
Shares exercised (in shares)	3,100,000	3,100,000
Number shares of unvested common stock (in shares)	17,300,000	17,300,000
Vesting period of stock options	4 years	4 years
Concentration Risk [Line Items]
Concentration percentage						98.00%